Beijing Bohui Innovation Biotechnology Group Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 532.01 million compared to CNY 498.74 million a year ago. Revenue was CNY 532.01 million compared to CNY 498.74 million a year ago. Net loss was CNY 28.21 million compared to net income of CNY 5.69 million a year ago. Basic loss per share from continuing operations was CNY 0.0345 compared to basic earnings per share from continuing operations of CNY 0.007 a year ago. Diluted loss per share from continuing operations was CNY 0.0345 compared to diluted earnings per share from continuing operations of CNY 0.007 a year ago.